The hepatitis C virus persistence: how to evade the immune system?
about
Hepatitis C virus and vaccine developmentCharacterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In VitroPretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to TherapyCorrelation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3aRETRACTED: Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA displayEffect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus InfectionHepatitis C virus antigenic convergenceAdvancement in the development of models for hepatitis C research.Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.Production and pathogenicity of hepatitis C virus core gene products.Efficient error correction for next-generation sequencing of viral amplicons.Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.New insight into HCV E1/E2 region of genotype 4a.Expression of bcl-2 protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy.Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.Next-generation sequencing reveals large connected networks of intra-host HCV variants.Prediction of prognostic biomarkers for interferon-based therapy to hepatitis C virus patients: a meta-analysis of the NS5A protein in subtypes 1a, 1b, and 3a.Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral responseApoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress.Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccineThe interferon inducing pathways and the hepatitis C virusHepatitis C virus infection and apoptosisDiversity in a honey bee pathogen: first report of a third master variant of the Deformed Wing Virus quasispeciesEnhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein ImmunizationImmunopharmacology of CpG oligodeoxynucleotides and ribavirin.Hepatitis C Virus E2 Protein Induces Upregulation of IL-8 Pathways and Production of Heat Shock Proteins in Human Thyroid Cells.Human Platelet Polymorphism can be a genetic marker associated with HIV/HCV coinfection.Hepatitis C virus: the role of molecular mimicry in response to interferon treatment.Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell lineImmunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.Modeling and analysis of innate immune responses induced by the host cells against hepatitis C virus infection.Occurrence and spatial distribution of hepatitis C in a Western Brazilian Amazon state.Association of human platelet antigens polymorphisms with susceptibility to hepatitis C virus infection in Chinese population.Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant.Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C.Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation.Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.The Tennessee study: factors affecting treatment outcome and healing time following nonsurgical root canal treatment.[Sustained virological response in patients with coinfection by hepatitis C virus genotypes 1 and 2, after just nine weeks of antiviral therapy: case report].[Characterization of hepatitis C virus in chronic hepatitis patients: genotypes in the State of Amazonas, Brazil].
P2860
Q27001610-5222D04C-F775-4169-A5AA-A14DBB8DC479Q27480361-B610DA29-52A7-4FB8-A5BF-C0F78410D967Q27481007-89278C95-5AD6-4BC3-BA2B-1DEB71667B85Q27486521-ED1B66ED-86B7-4E17-8AA7-B85DB411A04FQ27486984-5D46F9D6-40A8-44EF-9E9E-5912D648A554Q27490541-87387FEA-62E0-4270-B254-9677883DB3E8Q28732097-85F2819D-E74D-4AF7-BCB6-04F701CA5DB2Q30418069-81041B12-C907-4490-83C3-2922C77EB630Q33649735-E66ECDC5-5FB9-49DE-9829-9E44C32C28FCQ33780095-B3C0AE5E-E18A-4067-A349-A6CF84A65F7BQ34324713-5C99AB51-9653-4C0C-8503-62AA3B2DA309Q34756669-08A295FE-4353-4933-89A1-427A336D9271Q35005196-74F2AAE0-FADD-47C7-BE05-5F4E26BAA74AQ35010328-A49D4C52-297B-4432-BD9C-FAE60F5AA10AQ35056266-CD719AA6-BF1E-4B6A-94DD-E4EC63CE70A7Q35216806-80DEFB95-B0C8-42B2-B962-F37B06AC17E6Q35614537-B6A9C6C5-C735-4E3A-8BEA-EDB71E0B4B19Q35947547-382EE62D-83FB-4686-9A86-6AB373CA3116Q36074656-917A4616-90C1-45E2-94AD-F09A6BA7CAE5Q36117549-01740ED3-9E0F-4B0D-8449-0F7A7A88592DQ36841738-A36D5D72-5E20-4A2C-A79B-AE60DDBBB346Q36935539-44527C69-A3F5-4CB0-88A5-CAC232C6C1DCQ37268236-D9608ABC-D5EB-4879-8069-A3420C79078FQ37639093-6FE98791-0A89-40A4-8063-741921607924Q38340951-D10E2710-8B9A-425C-93D6-D19AF2EF3DB9Q38730457-9C4B603A-B0F0-4474-85AB-55ED00938EB7Q39034311-BB6EBB02-B257-4E4C-9D9E-3FF764525964Q39289109-F446036A-F045-414B-97E9-B23E31433863Q39438822-AE19ECA5-7B9B-48F9-AE92-798F6422EA73Q39712175-E4CA1084-1AC5-4408-892D-E0A9E3CCC1FCQ41107347-7D804C02-E361-4C69-91AA-01BD094B38F3Q41579248-FA57060C-578F-4935-96CC-F987B673C59EQ41934049-9731CFD7-A125-497B-A935-9B5CC56796CBQ42208607-09BFCF0C-667A-4412-96C8-FAFC6A2FF88DQ42978470-4BA1D991-127C-422C-B2A7-2DFF2C6C2DBFQ42990029-45B52356-59C1-4C24-A322-8FA7A6F538FAQ43041294-ADB54851-721D-482D-8AF4-E2E557FE2453Q48533636-AF147567-C02B-4402-885B-DE543FE85A5EQ50558168-AD81F124-18B0-4B16-9E29-62331D894EAAQ54342204-F29934BF-BCBF-485C-B7BE-65763E3CF1DA
P2860
The hepatitis C virus persistence: how to evade the immune system?
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The hepatitis C virus persistence: how to evade the immune system?
@ast
The hepatitis C virus persistence: how to evade the immune system?
@en
type
label
The hepatitis C virus persistence: how to evade the immune system?
@ast
The hepatitis C virus persistence: how to evade the immune system?
@en
prefLabel
The hepatitis C virus persistence: how to evade the immune system?
@ast
The hepatitis C virus persistence: how to evade the immune system?
@en
P2860
P356
P1476
The hepatitis C virus persistence: how to evade the immune system?
@en
P2093
Nicole Pavio
P2860
P2888
P304
P356
10.1007/BF02970148
P577
2003-04-01T00:00:00Z